IgG3 (Middle Region) Peptide
Reactivity: Human
Host: Synthetic
WB, BP
Catalog No. ABIN5671649
$160.46
Plus shipping costs $50.00
100 μg
Shipping to:
United States
Delivery in 11 to 16 Business Days
Quick Overview for IgG3 (Middle Region) Peptide (ABIN5671649)
Target
IgG3
Origin
Human
Source
Synthetic
Application
Western Blotting (WB), Blocking Peptide (BP)
-
-
Protein Region
- Middle Region
-
Sequence
- TKNQVSLTCL VKGFYPSDIA VEWESSGQPE NNYNTTPPML DSDGSFFLYS
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- IGHG3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
IgG3 peptide (Ovalbumin)
Reactivity: Mouse Host: Synthetic WB, Imm, SDS
IgG3 peptide (Ovalbumin)Reactivity: Mouse Host: Synthetic WB, Imm, SDS
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- IgG3
-
Target Type
- Antibody
-
Background
-
Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen.
Alias Symbols: IgG3
Protein Size: 377 -
Gene ID
- 3502
-
UniProt
- P01860
Target
-
You are here:
